[artículo] 
inEuropean Neuropsychopharmacology > Año 2018 - Vol. 28 - No. 6 (Junio) . - pp. 675-690

Título :	Translating molecular advances in down syndrome and fragile X syndrome into therapies
Tipo de documento:	texto impreso
Autores:	Victor Faundez, Autor ; Ilario De Toma, Autor ; Barbara Bardoni, Autor
Fecha de publicación:	2021
Artículo en la página:	pp. 675-690
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Síndrome de Down, Síndrome X frágil, Discapacidades intelectuales, células IPS, Estimulación cerebral, Neuroplasticidad
Resumen:	Ongoing treatments for genetic developmental disorders of the central nervous system are mostly symptomatic and do not correct the genetic cause. Recent identification of common mechanisms between diseases has suggested that new therapeutic targets could be applied across intellectual disabilities with potential disease-modifying properties.
Link:	./index.php?lvl=notice_display&id=26401

[artículo] Translating molecular advances in down syndrome and fragile X syndrome into therapies [texto impreso] / Victor Faundez, Autor ; Ilario De Toma, Autor ; Barbara Bardoni, Autor . - 2021 . - pp. 675-690.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2018 - Vol. 28 - No. 6 (Junio) . - pp. 675-690

Palabras clave:	Síndrome de Down, Síndrome X frágil, Discapacidades intelectuales, células IPS, Estimulación cerebral, Neuroplasticidad
Resumen:	Ongoing treatments for genetic developmental disorders of the central nervous system are mostly symptomatic and do not correct the genetic cause. Recent identification of common mechanisms between diseases has suggested that new therapeutic targets could be applied across intellectual disabilities with potential disease-modifying properties.
Link:	./index.php?lvl=notice_display&id=26401